ASTAZIN 10®

30 MODIFIED RELEASE TABLETS
<strong>ASTAZIN 10</strong>®

Food supplement based on Tagetes erecta, Astaxanthin, Bromelain, vitamins C, D3 and E, Copper and Zinc.

ASTAZIN10®is an association of Lutein from Tagetes erecta, Astaxanthin, Bromelain, vitamins C, D3 and E, Copper and Zinc that contribute to the maintenance of normal vision.
GLUTEN FREE – LACTOSE FREE
Astazin10
Lutein from Tagetes erecta, Astaxanthin, Bromelain, Vitamins C, D3 and E, Copper and Zinc
PROMOTES THE MAINTENANCE OF NORMAL VISION
astazin occhio

QUALITATIVE COMPOSITION

Bulking agent: Microcrystalline Cellulose (Cellulose gel), Calcium Phosphates; Vitamin C (L-Ascorbic acid); Anti-caking agents: fatty acids, Magnesium salts of fatty acids, Silicon dioxide, Croscarmellose sodium, Talc; Lutein from FloraGLO’ Tagetes erecta L (capitula) d.e. tit 10% (containing Zeaxanthine); Vitamin E (DL-alpha-tocopheryl acetate); Bromelain from Pineapple Comosus (L) Merr., (stipites) d.e. (2400 GDU/g); Zinc gluconate; Maltodextrine; Astaxanthin from Haematococcus pluvialis Flotow (thallus) d.e. tit.; Vitamin D3 (Cholecalciferol); Copper gluconate; Coating agents: Ethylcellulose, Hydroxypropylcellulose, Polyvinylpyrrolidone, Carnauba wax; Iron Oxide; Folic Acid (Pteroil-Monoglutamic Acid).

POSOLOGY AND METHOD OF ADMINISTRATION

1 tablet a day

SPECIAL WARNINGS

Do not exceed the recommended dose. The supplements are not intended as a substitute for a varied and balanced diet and a healthy lifestyle.

SPECIAL PRECAUTIONS FOR STORAGE

Store in a cool and dry place away from light and localized heat sources, sunlight and avoid contact with water. The expiry date refers to the product properly stored, in full packaging. Keep out of reach of children under three years.
Back to therapeutic area

SEGUICI ANCHE SUI NOSTRI CANALI SOCIAL

OMEGA PHARMA Srl a socio unico - Via Milano, 129 - 22063 Cantù (CO), Italy
Tel. +39 031 720135 - Fax +39.031.720273 - info@omegapharmasrl.com
P.Iva 05953070967 | Iscritta al registro imprese di Como – num. REA CO-295476 | Cap. soc. 104.000€ i.v.

Copyright OmegaPharma Srl